[D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: A promising concept in the prevention of cerebral vasospasm

Neurosurgical Review

Volumn 26, Issue 2, 2003, Pages 125-132

  Zimmermann, Michael ^a   Jung, Carla Sabine ^a   Vatter, Hartmut ^a   Raabe, Andreas ^a   Seifert, Volker ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

D Val22 big endothelin 1 16 38 ; Big endothelin 1; Cerebral vasospasm; Endothelin 1; Endothelin converting enzyme; Subarachnoid hemorrhage

Indexed keywords

BIG ENDOTHELIN 1; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; ENDOTHELIN DERIVATIVE; ASPARTIC PROTEINASE; BIG ENDOTHELIN 1(16 38), VALINE(22); BIG ENDOTHELIN-1(16-38), VALINE(22)-; ENDOTHELIN; ENDOTHELIN-CONVERTING ENZYME 1; GLYCOPEPTIDE; METALLOPROTEINASE; PHOSPHORAMIDON; PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; BASILAR ARTERY; BRAIN VASOSPASM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME INHIBITION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; SUBARACHNOID HEMORRHAGE; ANIMAL; DISEASE MODEL; DRUG ANTAGONISM; IN VITRO STUDY; MUSCLE CONTRACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; ASPARTIC ENDOPEPTIDASES; BASILAR ARTERY; DISEASE MODELS, ANIMAL; ENDOTHELINS; GLYCOPEPTIDES; MALE; METALLOENDOPEPTIDASES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; PROTEASE INHIBITORS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 0038072665     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-002-0242-9     Document Type: Article

References (57)

1. 2+ channels. J Hypertens Suppl 6:188-191
2. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M (1994) ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485
3. Emoto N, Yanagisawa M (1995) Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268
4. Fahnoe DC, Johnson GD, Herman SB, Ahn K (2000) Disulfide bonds in big ET-1 are essential for the specific cleavage at the Trp(21)-Val(22) bond by soluble endothelin converting enzyme-1 from baculovirus/insect cells. Arch Biochem Biophys 373:385-393
5. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S (1991) Conversion of big endothelin-1 to endothelin-1 by two-types of metalloproteinases of cultured porcine vascular smooth muscle cells. Biochem Biophys Res Commun 178:899-905
6. Turner AJ, Murphy LJ (1996) Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51:91-102
7. Zimmermann M, Seifert V, Loffler BM, Stolke D, Stenzel W (1996) Prevention of cerebral vasospasm after experimental sub-arachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery 38:115-120
8. Bax WA, Saxena PR (1994) The current endothelin receptor classification: time for reconsideration? Trends Pharmacol Sci 15:379-386
9. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348:730-732
10. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W (1993) Patho-physiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:759-761
11. Clozel M, Watanabe H (1993) BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52:825-834
12. Randall MD (1991) Vascular activities of the endothelins. Pharmacol Ther 50:73-93
13. Sakurai T, Yanagisawa M, Inoue A, Ryan US, Kimura S, Mitsui Y, Goto K, Masaki T (1991) cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem Biophys Res Commun 175:44-47
14. Schilling L, Feger GI, Ehrenreich H, Wahl M (1995) Endothelin-1-induced contraction and relaxation of isolated rat basilar artery: effect of the endothelium. J Cardiovasc Pharmacol 26 [Suppl 3]:197-199
15. Ehrenreich H, Schilling L (1995) New developments in the understanding of cerebral vasoregulation and vasospasm: the endothelin-nitric oxide network. Cleve Clin J Med 62:105-116
16. Feger GI, Schilling L, Ehrenreich H, Wahl M (1994) Endothelin-induced contraction and relaxation of rat isolated basilar artery: effect of BQ-123. J Cereb Blood Flow Metab 14:845-852
17. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H (1990) Effect of endothelin on the canine basilar artery. Neurosurgery 27:357-361
18. Zimmermann M, Seifert V (1998) Endothelin and subarachnoid hemorrhage: an overview. Neurosurgery 43:863-875
19. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735
20. Seifert V, Loffier BM, Zimmermann M, Roux S, Stolke D (1995) Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vaso-spasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82:55-62.
21. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S (1990) Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 81:553-554
22. Vila JM, Martin DA, Irurzun A, Aldasoro M, Flor B, Lluch S (1992) Contractile response of human omental arteries to endothelin. J Pharm Pharmacol 44:105-108
23. Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS (1996) Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage. J Neurosurg 85:917-922
24. Warner TD, Battistini B, Doherty AM, Corder R (1994) Endothelin receptor antagonists: actions and rationale for their development. Biochem Pharmacol 48:625-635
25. Wilson C, Hargreaves RB (1994) Inhibition of the pharmacological effects of endothelin. Prog Med Chem 31:371-410
26. Parnot C, Le Moullec JM, Cousin MA, Guedin D, Corvol P, Pinet F (1997) A live-cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension 30:837-844
27. Morita A, Nomizu M, Okitsu M, Horie K, Yokogoshi H, Roller PP (1994) D-Val22 containing human big endothelin-1 analog, [D-Val22]Big ET-1[16-38], inhibits the endothelin converting enzyme. FEBS Lett 353:84-88
28. Vatter H, Schilling L, Schmiedek P, Ehrenreich H (1998) Evidence for functional endothelin-converting enzyme activity in isolated rat basilar artery: effect of inhibitors. J Cardiovasc Pharmacol 31[Suppl 1]:64-67
29. Seifert V, Stolke D, Reale E (1989) Ultrastructural changes of the basilar artery following experimental subarachnoid haemorrhage. A morphological study on the pathogenesis of delayed cerebral vasospasm. Acta Neurochir (Wien) 100:164-171
30. Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, Yosizumi M, Yazaki Y, Takakura K (1989) The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res 11:101-104
31. Cocks TM, Malta E, King SJ, Woods RL, Angus JA (1991) Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in culture. Eur J Pharmacol 196:177-182
32. Fujiwara S, Kassell NF, Sasaki T, Nakagomi T, Lehman RM (1986) Selective hemoglobin inhibition of endothelium-depen-dent vasodilatation of rabbit basilar artery. J Neurosurg 64:445-452
33. Kasuya H, Weir BK, White DM, Stefansson K (1993) Mechanism of oxyhemoglobin-induced release of endothelin-1 from cultured vascular endothelial cells and smooth-muscle cells. J Neurosurg 79:892-898
34. Hongo T, Kupfer J, Enomoto H, Sharifi B, Giannella-Neto D, Forrester JS, Singer FR, Goltzman D, Hendy GN, Pirola C (1991) Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J Clin Invest 88:1841-1847
35. Juvela S, Hillbom M, Kaste M (1991) Platelet thromboxane release and delayed cerebral ischemia in patients with sub-arachnoid hemorrhage. J Neurosurg 74:386-392
36. Hongo K, Kassell NF, Nakagomi T, Sasaki T, Tsukahara T, Ogawa H, Vollmer DG, Lehman RM (1988) Subarachnoid hemorrhage inhibition of endothelium-derived relaxing factor in rabbit basilar artery. J Neurosurg 69:247-253
37. Nosko M, Schulz R, Weir B, Cook DA, Grace M (1988) Effects of vasospasm on levels of prostacyclin and thrombox-ane A2 in cerebral arteries of the monkey. Neurosurgery 22:45-50
38. Seifert V, Eisert WG, Stolke D, Goetz C (1989) Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage. Neurosurgery 25:590-598
39. Seifert V, Stolke D, Kaever V, Dietz H (1987) Arachidonic acid metabolism following aneurysm rupture. Evaluation of cerebrospinal fluid and serum concentration of 6-keto-prostaglandin F1 alpha and thromboxane B2 in patients with sub-arachnoid hemorrhage. Surg Neurol 27:243-252
40. Papadopoulos SM, Gilbert LL, Webb RC, D'Amato CJ (1990) Characterization of contractile responses to endothelin in human cerebral arteries: implications for cerebral vasospasm. Neurosurgery 26:810-815
41. Asano T, Ikegaki I, Satoh S, Suzuki Y, Shibuya M, Sugita K, Hidaka H (1990) Endothelin: a potential modulator of cerebral vasospasm. Eur J Pharmacol 190:365-372
42. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, Takakura K, Shigeno T (1990) Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage. Lancet 336:633
43. Mima T, Yanagisawa M, Shigeno T, Saito A, Goto K, Takakura K, Masaki T (1989) Endothelin acts in feline and canine cerebral arteries from the adventitial side. Stroke 20:1553-1556
44. Matsumura Y, Ikegawa R, Tsukahara Y, Takaoka M, Morimoto S (1990) Conversion of big endothelin-1 to endothelin-1 by two types of metalloproteinases derived from porcine aortic endothelial cells. FEBS Lett 272:166-170
45. Matsumura Y, Ikegawa R, Suzuki Y, Takaoka M, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe M, Morimoto S (1991) Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49:841-848
46. Cosentino F, McMahon EG, Carter JS, Katusic ZS (1993) Effect of endothelin A-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22[Suppl 8]:332-335
47. Breu V, Loffier BM, Clozel M (1993) In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors. FEBS Lett 334:210-214
48. Roux S, Loffier BM, Gray GA, Sprecher U, Clozel M, Clozel JP (1995) The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37:78-85
49. Itoh S, Sasaki T, Ide K, Ishikawa K, Nishikibe M, Yano M (1993) A novel endothelin ETA receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195:969-975
50. Shigeno T, Clozel M, Sakai S, Saito A, Goto K (1995) The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 37:87-90
51. Onoda K, Ono S, Ogihara K, Shiota T, Asari S, Ohmoto T, Ninomiya Y (1996) Inhibition of vascular contraction by intracisternal administration of preproendothelin-1 mRNA antisense oligoDNA in a rat experimental vasospasm model. J Neurosurg 85:846-852
52. Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM (1999) Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage. J Neurosurg 90:1105-1114
53. Schilling L, Vatter H, Mursch K, Ehrenreich H, Schmiedek P (2000) Characterization of the contractile and relaxant action of the endothelin-1 precursor, big endothelin-1, in the isolated rat basilar artery. Peptides 21:91-99
54. Saito A, Shiba R, Yanagisawa M, Masaki T, Kimura S, Yamada K, Mima T, Shigeno T, Goto K (1991) Endothelins: vasoconstrictor effects and localization in canine cerebral arteries. Br J Pharmacol 103:1129-1135
55. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S (1990) Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme. Biochem Biophys Res Commun 171:669-675
56. Kukkola PJ, Savage P, Sakane Y, Berry JC, Bilci NA, Ghai RD, Jeng AY (1995) Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. J Cardiovasc Pharmacol 26[Suppl 3]:65-68
57. Matsumura Y, Tsukahara Y, Kuninobu K, Takaoka M, Morimoto S (1992) Phosphoramidon-sensitive endothelin-converting enzyme in vascular endothelial cells converts big endothelin-1 and big endothelin-3 to their mature form. FEBS Lett 305:86-90